Amylyx Pharmaceuticals (AMLX) Treasury Shares (2022 - 2026)

Amylyx Pharmaceuticals' Treasury Shares history runs 5 years deep, the most recent figure standing at $3.9 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 23.92% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (up 23.92% YoY), while the FY2025 annual figure was $2.7 million, up 23.15% from the prior year.
• Treasury Shares was $3.9 million for Q1 2026 at Amylyx Pharmaceuticals, up from $2.7 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.9 million in Q1 2026 to a low of $596709.0 in Q1 2022.
• Historically, Treasury Shares has averaged $1.9 million across 5 years, with a median of $2.1 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares soared 174.08% in 2024, then increased 7.86% in 2025.
• A 5-year view of Treasury Shares shows it stood at $740297.0 in 2022, then soared by 50.28% to $1.1 million in 2023, then surged by 98.91% to $2.2 million in 2024, then advanced by 23.15% to $2.7 million in 2025, then jumped by 44.33% to $3.9 million in 2026.
• The last three Treasury Shares figures came in at $3.9 million (Q1 2026), $2.7 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.